Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance.

Mondini M, Loyher PL, Hamon P, Gerbé de Thoré M, Laviron M, Berthelot K, Clémenson C, Salomon BL, Combadière C, Deutsch E, Boissonnas A.

Cancer Immunol Res. 2019 Mar;7(3):376-387. doi: 10.1158/2326-6066.CIR-18-0633. Epub 2019 Jan 29.

PMID:
30696630
2.

Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.

Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL.

Front Immunol. 2018 Mar 12;9:444. doi: 10.3389/fimmu.2018.00444. eCollection 2018. Review.

3.

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer.

Ivagnès A, Messaoudene M, Stoll G, Routy B, Fluckiger A, Yamazaki T, Iribarren K, Duong CPM, Fend L, Caignard A, Cremer I, LeCesne A, Adam J, Honoré C, Mir O, Chaigneau L, Berger A, Validire P, Christidis C, Brun-Ly VL, Smyth MJ, Mariette X, Salomon BL, Kroemer G, Rusakiewicz S, Zitvogel L.

Oncoimmunology. 2017 Oct 11;7(12):e1386826. doi: 10.1080/2162402X.2017.1386826. eCollection 2018.

4.

Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells.

Leclerc M, Naserian S, Pilon C, Thiolat A, Martin GH, Pouchy C, Dominique C, Belkacemi Y, Charlotte F, Maury S, Salomon BL, Cohen JL.

Blood. 2016 Sep 22;128(12):1651-9. doi: 10.1182/blood-2016-02-700849. Epub 2016 Aug 9.

PMID:
27506541
5.

Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression.

Goldstein JD, Burlion A, Zaragoza B, Sendeyo K, Polansky JK, Huehn J, Piaggio E, Salomon BL, Marodon G.

PLoS One. 2016 Apr 14;11(4):e0153682. doi: 10.1371/journal.pone.0153682. eCollection 2016. Erratum in: PLoS One. 2016;11(6):e0157629.

6.

Treatment of Uveitis by In Situ Administration of Ex Vivo-Activated Polyclonal Regulatory T Cells.

Grégoire S, Terrada C, Martin GH, Fourcade G, Baeyens A, Marodon G, Fisson S, Billiard F, Lucas B, Tadayoni R, Béhar-Cohen F, Levacher B, Galy A, LeHoang P, Klatzmann D, Bodaghi B, Salomon BL.

J Immunol. 2016 Mar 1;196(5):2109-18. doi: 10.4049/jimmunol.1501723. Epub 2016 Jan 29.

7.

Suppressive activity of human regulatory T cells is maintained in the presence of TNF.

Zaragoza B, Chen X, Oppenheim JJ, Baeyens A, Gregoire S, Chader D, Gorochov G, Miyara M, Salomon BL.

Nat Med. 2016 Jan;22(1):16-7. doi: 10.1038/nm.4019. No abstract available.

8.

Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance.

Gupta N, Culina S, Meslier Y, Dimitrov J, Arnoult C, Delignat S, Gangadharan B, Lecerf M, Justesen S, Gouilleux-Gruart V, Salomon BL, Scott DW, Kaveri SV, Mallone R, Lacroix-Desmazes S.

Sci Transl Med. 2015 Feb 18;7(275):275ra21. doi: 10.1126/scitranslmed.aaa1957.

PMID:
25696000
9.

Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.

Baeyens A, Saadoun D, Billiard F, Rouers A, Grégoire S, Zaragoza B, Grinberg-Bleyer Y, Marodon G, Piaggio E, Salomon BL.

J Immunol. 2015 Feb 1;194(3):999-1010. doi: 10.4049/jimmunol.1400504. Epub 2014 Dec 29.

10.

Highly self-reactive naive CD4 T cells are prone to differentiate into regulatory T cells.

Martin B, Auffray C, Delpoux A, Pommier A, Durand A, Charvet C, Yakonowsky P, de Boysson H, Bonilla N, Audemard A, Sparwasser T, Salomon BL, Malissen B, Lucas B.

Nat Commun. 2013;4:2209. doi: 10.1038/ncomms3209.

PMID:
23900386
11.

In vivo activation of transferred regulatory T cells specific for third-party exogenous antigen controls GVH disease in mice.

Martin GH, Grégoire S, Landau DA, Pilon C, Grinberg-Bleyer Y, Charlotte F, Mège JP, Chatenoud L, Salomon BL, Cohen JL.

Eur J Immunol. 2013 Sep;43(9):2263-72. doi: 10.1002/eji.201343449. Epub 2013 Jul 9. Erratum in: Eur J Immunol. 2014 Jul;44(7):2197.

12.

Fetal pancreas transplants are dependent on prolactin for their development and prevent type 1 diabetes in syngeneic but not allogeneic mice.

Fourcade G, Colombo BM, Grégoire S, Baeyens A, Rachdi L, Guez F, Goffin V, Scharfmann R, Salomon BL.

Diabetes. 2013 May;62(5):1646-55. doi: 10.2337/db12-0448. Epub 2013 Feb 19.

13.

[Could we cure type 1 diabetes by stimulating T(reg)?].

Grinberg-Bleyer Y, Baeyens A, Piaggio E, Salomon BL.

Med Sci (Paris). 2011 May;27(5):471-2. doi: 10.1051/medsci/2011275008. Epub 2011 May 25. French. No abstract available.

14.

Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.

Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, Grégoire S, Martin GH, Elhage R, Derian N, Carpentier W, Marodon G, Klatzmann D, Piaggio E, Salomon BL.

J Clin Invest. 2010 Dec;120(12):4558-68. doi: 10.1172/JCI42945. Epub 2010 Nov 22.

15.

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells.

Grinberg-Bleyer Y, Baeyens A, You S, Elhage R, Fourcade G, Gregoire S, Cagnard N, Carpentier W, Tang Q, Bluestone J, Chatenoud L, Klatzmann D, Salomon BL, Piaggio E.

J Exp Med. 2010 Aug 30;207(9):1871-8. doi: 10.1084/jem.20100209. Epub 2010 Aug 2.

16.

Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.

Darrasse-Jèze G, Bergot AS, Durgeau A, Billiard F, Salomon BL, Cohen JL, Bellier B, Podsypanina K, Klatzmann D.

J Clin Invest. 2009 Sep;119(9):2648-62. doi: 10.1172/JCI36628. Epub 2009 Aug 3.

17.

Clinical grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene: authors' reponse.

Guillot-Delost M, Cheraï M, Hamel Y, Rosenzwajg M, Baillou C, Simonin G, Leclercq V, Mariotti-Ferrandiz ME, Six A, Bon-Durand V, Maury S, Salomon BL, Cohen JL, Klatzmann D, Lemoine FM.

J Gene Med. 2009 Aug;11(8):737-8. doi: 10.1002/jgm.1358. No abstract available.

PMID:
19514009
18.

Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene.

Guillot-Delost M, Cheraï M, Hamel Y, Rosenzwajg M, Baillou C, Simonin G, Leclercq V, Mariotti-Ferrandiz ME, Six A, Bon-Durand V, Maury S, Salomon BL, Cohen JL, Klatzmann D, Lemoine FM.

J Gene Med. 2008 Aug;10(8):834-46. doi: 10.1002/jgm.1220.

PMID:
18615770
19.

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA.

Immunity. 2008 May;28(5):687-97. doi: 10.1016/j.immuni.2008.03.016. Epub 2008 May 8.

20.

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, Delignat S, Elluru S, Bayry J, Lacroix-Desmazes S, Cohen JL, Salomon BL, Kazatchkine MD, Kaveri SV, Misra N.

Blood. 2008 Jan 15;111(2):715-22. Epub 2007 Oct 11.

PMID:
17932250
21.

Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse.

Bour-Jordan H, Salomon BL, Thompson HL, Santos R, Abbas AK, Bluestone JA.

J Immunol. 2007 Jul 15;179(2):1004-12.

22.

Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation.

Billiard F, Litvinova E, Saadoun D, Djelti F, Klatzmann D, Cohen JL, Marodon G, Salomon BL.

J Immunol. 2006 Aug 15;177(4):2167-74.

23.

Regulatory T cells in graft-versus-host disease.

Salomon BL, Sudres M, Cohen JL.

Springer Semin Immunopathol. 2006 Aug;28(1):25-9. Epub 2006 Jun 29. Review.

PMID:
16838181
24.

Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors.

Marodon G, Fisson S, Levacher B, Fabre M, Salomon BL, Klatzmann D.

Blood. 2006 Nov 1;108(9):2972-8. Epub 2006 Jun 29.

PMID:
16809618
25.

Regulatory T cells control uveoretinitis induced by pathogenic Th1 cells reacting to a specific retinal neoantigen.

Terrada C, Fisson S, De Kozak Y, Kaddouri M, Lehoang P, Klatzmann D, Salomon BL, Bodaghi B.

J Immunol. 2006 Jun 15;176(12):7171-9.

26.

Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage.

Cabarrocas J, Cassan C, Magnusson F, Piaggio E, Mars L, Derbinski J, Kyewski B, Gross DA, Salomon BL, Khazaie K, Saoudi A, Liblau RS.

Proc Natl Acad Sci U S A. 2006 May 30;103(22):8453-8. Epub 2006 May 18.

27.

Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire.

Fisson S, Djelti F, Trenado A, Billiard F, Liblau R, Klatzmann D, Cohen JL, Salomon BL.

Eur J Immunol. 2006 Apr;36(4):817-27.

28.

Natural regulatory T cells control the development of atherosclerosis in mice.

Ait-Oufella H, Salomon BL, Potteaux S, Robertson AK, Gourdy P, Zoll J, Merval R, Esposito B, Cohen JL, Fisson S, Flavell RA, Hansson GK, Klatzmann D, Tedgui A, Mallat Z.

Nat Med. 2006 Feb;12(2):178-80. Epub 2006 Feb 5.

PMID:
16462800
29.

Ex vivo-expanded CD4+CD25+ immunoregulatory T cells prevent graft-versus-host-disease by inhibiting activation/differentiation of pathogenic T cells.

Trenado A, Sudres M, Tang Q, Maury S, Charlotte F, Grégoire S, Bonyhadi M, Klatzmann D, Salomon BL, Cohen JL.

J Immunol. 2006 Jan 15;176(2):1266-73.

30.

CD4+CD25+ regulatory/suppressor T cells prevent allogeneic fetus rejection in mice.

Darrasse-Jèze G, Klatzmann D, Charlotte F, Salomon BL, Cohen JL.

Immunol Lett. 2006 Jan 15;102(1):106-9. Epub 2005 Aug 3. Erratum in: Immunol Lett. 2006 Feb 15;102(2):241. Darasse-Jèze, Guillaume [corrected to Darrasse-Jèze, Guillaume].

PMID:
16199095
31.

Therapeutic potential of CD4+ CD25+ regulatory T cells in allogeneic transplantation.

Cohen JL, Salomon BL.

Cytotherapy. 2005;7(2):166-70. Review.

PMID:
16040396
32.

Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses.

Darrasse-Jèze G, Marodon G, Salomon BL, Catala M, Klatzmann D.

Blood. 2005 Jun 15;105(12):4715-21. Epub 2005 Feb 24.

PMID:
15731180
33.

Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Bour-Jordan H, Salomon BL, Thompson HL, Szot GL, Bernhard MR, Bluestone JA.

J Clin Invest. 2004 Oct;114(7):979-87.

34.

CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86.

Orabona C, Grohmann U, Belladonna ML, Fallarino F, Vacca C, Bianchi R, Bozza S, Volpi C, Salomon BL, Fioretti MC, Romani L, Puccetti P.

Nat Immunol. 2004 Nov;5(11):1134-42. Epub 2004 Oct 3.

PMID:
15467723
35.
36.

Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, Cohen JL.

J Clin Invest. 2003 Dec;112(11):1688-96.

37.

Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

Fisson S, Darrasse-Jèze G, Litvinova E, Septier F, Klatzmann D, Liblau R, Salomon BL.

J Exp Med. 2003 Sep 1;198(5):737-46. Epub 2003 Aug 25.

38.

CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease.

Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL.

J Exp Med. 2002 Aug 5;196(3):401-6.

Supplemental Content

Loading ...
Support Center